Connect with us

Farnam Street Investments April 2020 Commentary

Farnam Street Investments April 2020 Commentary

Published

on

investment game plan capital losses berna barshay SOX 404 Digitizing Asset Management strategic investors

Farnam Street Investments commentary for the month of April 2020, briefly discussing their investment game plan.

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q1 2020 hedge fund letters, conferences and more

"If you are uneasy, welcome to the club.” - Charlie Munger on 2/12/2020, before everything hit the fan

Life comes at you fast. Volatility came roaring back to the markets in an historic fashion. We sent out a Special Update on March 16th explaining the investment game plan. I won’t fully rehash it here, but the short answer is opportunistic gradualism. We’ll slowly accumulate businesses we’ve coveted for years as prices come to us. I’m hesitant to make any bold proclamations, as it feels like we’re still in Act 1 of this particular saga. One-in-a-hundred year pandemics are bleak, yet this too shall pass. Howard Marks has a great line in one of his recent memos: “The investor’s goal should be to make a large number of good buys, not just a few perfect ones.”

After a few years of being closed to new investors, Farnam Street is taking on new clients in anticipation of opportunities. Introduce us to your friends and family who could use a steady financial hand. Despite a recent bounce back in stocks, it’s likely the storm is still brewing. Markets punish complacency. As the sage philosopher Mike Tyson once said, “Everyone has a plan until they get punched in the mouth.”

The rest of the letter will feel incongruent with the rapid inundation of developing storylines. Each day brings us new scary headlines of hospitalizations, contagion, unemployment, debt crises, and bailouts. Our species is choosing the best of bad options, as the faultlines of our fragility are laid bare.

Errors originate from blindspots. And emotional thinking is the shortest path to throwing on blinders. It helps to keep calm and focused by engaging what psychologist Daniel Kahneman calls System 2 thinking. Slow down. Be methodical. Prepare. Follow your game plan. Don’t under- or over-react. Zoom out. Accept reality without bargaining.

Big Data

“It’s what you learn after you know it all that counts.” - John Wooden

How do we know things? Like “Capital-T Truth” know, for certain. It’s scary to stop and think how many of your beliefs and lenses to interpret the world derive from what you were told as a younger self.

The scientific method was developed in the early 17th-century by an English philosopher named Francis Bacon. Before that, the “truth” was generally formed from guesses, mythology, and whatever authorities had to say on the subject. The Enlightenment wasn’t far behind as we gained tremendous insight into the workings of our physical world. And on its heels came the Industrial Revolution as we harnessed science for material improvement.

Theory, experimentation, implementation, commercialization. Rinse and repeat.

One of the key tenants of the scientific method is data collection. Generally, the more data, the better. We need a large and representative sample size (n) if we want to make predictions about a population or phenomena.

When it comes to the world of investing, a tremendous amount of data are generated, but the relevant n is often laughably small. Take market prices. We can look at millions of minute-by-minute squiggles of the ticker. But how big is our n for the major moves which truly matter? There have been sixteen bear markets since 1926 according to Fidelity. Any statistician worth their salt will tell you sixteen data points won’t generally provide much explanatory power. Our millions of daily prices show that all datasets aren’t created equal. So when I tell you these sixteen bear markets have lasted an average of 22 months and claw back an average of -39%, you should maintain a healthy skepticism. We simply can’t say much about any bear market, or bull for that matter. We’re muzzled by small sample sizes.

Keep in mind that facts are like radioactive material--they have a half-life3. Facts decay in a probabilistic fashion based on the domain where they reside. This makes reading widely and continually updating your “facts” of paramount importance. As Goethe said, “He who moves not forward, goes backward.” How tall is Mount Everest? The exact height of the mountain changes by the second based on a balance of plate tectonics pushing up and wind erosion scrubbing off. That “fact” changed since you started reading this letter.

On the other end of the half-life spectrum resides physics. Aristotle had a description of facts about our physical world which persisted for centuries. We had improvements from Copernicus, Kepler, Galileo, and Descartes. Then along came Newton and calculus to change the game. Of course, Einstein’s relativity was next to kick over the apple cart. Who knows what follows and when, but there’s likely something after relativity in this millennium.

If you’re an ardent truth-seeker, where can you look to find a large enough n to give you confidence you’re on robust footing? Where is the real big data?

Here are three possible answers, in order of explanatory power. I’ll frame the familiar concept of reciprocity as viewed through these three prisms, and then provide the takeaways for an investment context.

1. The Inorganic Universe

“Time obliterates the fictions of opinion and confirms the decisions of nature.” - Marcus Tullius Cicero

The best guess is our universe is 13.7 billion years old. That’s what an epistemologist would call an “empirically big-ass dataset.” We can have reasonable confidence that shrewd analogies drawn from physics are likely to provide insights.

Newton’s Third Law states that for every action, there is an equal and opposite reaction. In math, we call it reversion to the mean. Quite literally in astrophysics, what goes around (a planet) comes around. The universe seems to like to keep the score even.

2. Biology

“Nature uses only the longest threads to weave her patterns, so that each small piece of her fabric reveals the organization of the entire tapestry.” - Richard Feynman

Life has been on earth for roughly 3.7 billion years. The branching and evolving of life has generated an incredible number of interactions to catalog and decipher. It’s our next best data set.

Evidence suggests that the eukaryotic cells that we’re all made of originated when two simple bacteria teamed up together. One may have contributed protection and food with its lipid membrane while the other supplied energy as a mitochondria inside its new friend. It’s notable that the recipe for your mitochondria comes solely from your mother’s lineage.

This biological reciprocity conveyed survival advantages. Both sides were better off by the arrangement. We have a similarly symbiotic relationship with our gut bacteria. Tit-for-tat has been around for billions of years and has proven an evolutionarily stable strategy.

3. Human History

“If you want to go fast, go alone. If you want to go far, go together.” - African Proverb

Recorded history goes back roughly 5,000 years to Sumerian cuneiform, however our species is likely ~2 million years old. Most of that time we roamed the savannah as small bands of hunter-gatherers.

A hunter-gatherer lifestyle served up a full helping of random chance. Some days you caught your prey. Some days you were skunked. And some days your prey caught you. Meat from your kill spoiled quickly3. One survival mechanism we evolved was to “store” meat in our fellow human’s stomach. When our hunt came up empty, a friend shared their kill, and vice versa. It was an early instance of insurance and we got good at keeping score. By coordinating our efforts and sharing the results, our cooperation improved our odds of survival. Nature wired reciprocity as genetic instinct.

Hence we hear the timeless wisdom of karma, the golden rule, or “an eye for an eye.” We have a highly evolved sense of when we’re being cheated, and a visceral fear of being ostracized from the tribe (the brain-chemistry cocktail known as “shame”). It was a literal death sentence during our formative years. Drawing inference from three staggeringly large data sets, we can safely say that reciprocity is a solid building block of knowledge.

The investment consequences are profound.

Going All-In

Due to reciprocity, any economic organism, what we’d colloquially call “a business,” is only sustainable if all of its relationships are win-win. A business can take advantage of counterparties for periods of time, but eventually the other side will seek retribution. There are no examples of a business that can permanently cheat stakeholders. Zero.

Management’s job is to recognize how their business interacts with its environment, and then structure win-win relationships with six key counterparties, peeking at their cards to figure out what they seek3:

  1. Suppliers - stability--if you keep them busy, they’ll keep you price competitive
  2. Customers - perceived value has to be greater than the price paid
  3. Employees - financial and non-financial recognition, stability, the opportunity to own a house in a safe neighborhood, provide their kids' an education, and a reasonable retirement
  4. Owners - investment has to provide superior returns, low risk, and long duration
  5. Regulators - want to look good and not show up in the newspaper for allowing bad behavior
  6. Communities - provide jobs, don't pollute their backyards

Win-win keeps other parties from searching for a Plan B. They feel safe to go “all-in” on the relationship. The normal distribution of outcomes of the dog-eat-dog world loses relevance.

Every miracle is an all-in phenomenon. Two simple bacteria Voltron to form complex life. A soldier lays down his life for his platoon. The crackling energy of an early start-up. The 1980 US Hockey team. True love. All-in is the magic ingredient.

It’s a sad reflection of short-term thinking, but most publicly-traded companies routinely violate one of these win-win relationships. Too many managerial actions betray being all-in for their company. In these cases, they’re instead all-in for themselves. Much of the commercial universe is uninvestable for those optimizing for the truly long game. They aren’t sustainable businesses when viewed through our big data prisms. It’s important to remember there are shades of gray whenever humans are involved. We can’t abandon critical thinking; there are no pure angels or demons.

In summary, the big data of physics, biology, and history can provide us intellectual-terra-firm to interpret the diminutive dataset domains of the investment world.

Quick Housekeeping Items

  • Part of being a registered investment advisor with the State of California means providing compliance updates and disclosures annually. Here’s where we keep the most up-to-date documents for our clients: https://www.dropbox.com/sh/sp5mqetpcwrjc1b/AABxGZXC6vKI-AFosZam6xita?dl=0
  • In March, we added a new team member to Farnam Street. Brian Miller was one of our favorite students from our teaching days at UC Davis’s MBA program. Due to his aptitude and high moral fiber, we kept an eye on him and enjoyed watching his career blossom. Brian was an obvious fit after he expressed interest in joining our little firm. He’ll be coming aboard as an investment advisor and will provide a much needed Bay Area presence. Welcome, Brian!

As always, we’re thankful to have such great partners in this wealth creation journey.

Jake & Lonnie

The post Farnam Street Investments April 2020 Commentary appeared first on ValueWalk.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Typhoid Conjugate Vaccine Introduction in Madagascar vaccination

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending